ICO KYC Report
2 members invited
Ratings
All ratings published on ICObench serve informational purposes only. ICObench does not provide investment forecast, recommendations or any consulting for that matter. Thus, neither ICObench, nor the experts can be hold responsible for the visitors’ investment decisions. Read more
Igor Karavaev
ICO and STO and IEO advisor
Rated on Jul 4, 2018
Modified on Jul 4, 2018
Rated on Jul 4, 2018
Modified on Jul 4, 2018
5
4
5
11%
The biotech industry has a great perspective using blockchain. This team is reinforced and quite numerous. This is a project with a good potential if well implemented. The WP still should be a bit improved as comes to numbers.
+4Agree
-5
-9Disagree
Report
Hung Chih (Jason Hung)
Cofounder of International Consensus Association | Investor Relation | China Market
Rated on May 19, 2018
Rated on May 19, 2018
5
5
4
11%
The project intend to build transparency ecosystem for biotech and encourage the participation by using token as a media. It's a good direction and I looking forward to see it works.
However, from my many years experience of doing business with biotech, the player in biotech industry is usually very conservation and self-protected.
So, I think the challenge is not technology but how to promote and convincing all player. The core team is strong, but I will recommend invite more channel and sales partner to speed up market adaption.
Good luck!
+1Agree
0
-1Disagree
Report
Nikolay Shkilev
PhD | Entrepreneur | CEO | ICO Advisor | Crypto enthusiast | Blockchain expert | Public speaker | Mentor
Rated on May 27, 2018
Rated on May 27, 2018
5
5
4
11%
UPD: Good and big team.
Great vision. And biotech is huge market.
MVP - will soon!
KYC - passed it's good
Vision is good
Need more strong marketing and PR
+3Agree
+2
-1Disagree
Report
Brian Condenanza
ICO and IEO Advisor | TEDx Speaker | Cryptopreneur | ICOBench Expert | Revista Bitcoin Editor | Blockchain and Cryptocurrency Researcher
Rated on Sep 7, 2018
Modified on Sep 7, 2018
Rated on Sep 7, 2018
Modified on Sep 7, 2018
5
4
4
10%
Very interesting product, although this is a very hard ecosystem to break in, as biotech breakthroughs can be very expensive to get. Great team and advisory board. Good luck team!
Agree
0
Disagree
Report
Vlad Skakun
ICO Advisor | Investor| Marketing Specialist| Senior Analyst at Venture Fund
Rated on May 21, 2018
Rated on May 21, 2018
5
5
5
9%
Nowadays biotech industry is very promising and implementation blockchain technology in it could provide a great competitive advantage to the project.
GENEXI wants to create not just some local solution but a complex product which will help to solve the problem of the supply chain, drug counterfeit, fraud and quality manipulation.
They have a solid and experienced team in the business sphere. Their MVP will be launched in Q3 this year, keep waiting.
+2Agree
0
-2Disagree
Report
Vladimir Manzyuk
Blockchain/System Analyst
Rated on May 24, 2018
Rated on May 24, 2018
5
5
5
8%
In my opinion:
- Good team
- Nice vision
- The fact that the company is registered in Switzerland is a big plus for investors
- The market has high CAGR
+1Agree
+1
Disagree
Report
Suraj Tiwari
ICO ADVISOR CONSULTING EXCHANGES Listing SMART CONTRACT TOKEN CODE
Rated on Jun 14, 2018
Rated on Jun 14, 2018
3
4
3
5%
Team : looks great but when checked linked most of them either dont have it or have few connections.
Vision is good but i think they have to work very hard for it.
Product : cant see any prototype though the website was awesome but cant rate a website.
+1Agree
0
-1Disagree
ReportExperts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.